Login / Signup

Genome-Editing Products Line up for the Market: Will Europe Harvest the Benefits from Science and Innovation?

Alexios N PolidorosIrini Nianiou-ObeidatNikolaos TsakirpaloglouNestor PetrouEleftheria DeligiannidouNefeli-Maria Makri
Published in: Genes (2024)
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technologies have revolutionized genome editing, significantly advancing the improvement of cultivated crop species. This review provides an overview of genome-edited crops that have either reached the market or received the necessary approvals but are not yet available to consumers. We analyze various genome-editing studies to understand the distribution of different genome-editing systems, the types of site-directed nucleases employed, and the geographical spread of these studies, with a specific focus on global and European contexts. Additionally, we examine the target crops involved. The review also outlines the multiple steps required for the legal acceptance of genome-edited crops within European jurisdictions. We conclude with suggestions for the future prospects of genome-editing research in Europe, aiming to streamline the approval process and enhance the development and adoption of genome-edited crops.
Keyphrases
  • genome editing
  • crispr cas
  • genome wide
  • current status
  • health insurance
  • climate change
  • gene expression
  • drug administration